COV up +1.57% percent Today $COV High is at 94.34 and the Low 92.87 with current volume of 565,792.
Recent News posted below.
Covidien Plc. COV other info.
http://investorshangout.com/Covidien-Plc-COV-50596/
COV Covidien Plc. Recent Headline News
Form 8.1 - Covidien
Business Wire - 21 mins ago
Covidien plc:
COV: 93.80 (+0.92)
Insider Trading Alert - CTSH, PSEC And COV Traded By Insiders
at The Street - 1 hr 23 mins ago
Stocks with insider trader activity include CTSH, PSEC and COV
COV: 93.80 (+0.92), CTSH: 53.42 (+0.18), PSEC: 9.74 (+0.05)
Covidien Shares Up 28.9% Since SmarTrend's Buy Recommendation (COV)
Comtex SmarTrend(R) - Wed Nov 12, 9:16AM CST
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 28.91% as of today's recent price of $93.02.
COV: 93.80 (+0.92)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 133.14 (+2.05), MDT: 69.39 (+0.89), C: 53.24 (-0.18), WMT: 82.04 (+2.84), RBS: 11.76 (-0.06), UBS: 17.55 (+0.17), NOK: 8.24 (+0.19), YHOO: 50.17 (-0.43), PBR: 10.44 (-0.12), SPY: 204.32 (+0.36), SAP: 66.44 (-0.01), EBAY: 54.41 (+0.35), JPM: 60.45 (-0.11), BHP: 58.03 (-0.15), AAPL: 113.06 (+1.81), BCS: 14.43 (-0.15), FRM: 6.33 (-0.26), COV: 93.80 (+0.92), HSBC: 50.17 (-0.05), FRGI: 56.07 (-0.60), ZTS: 43.08 (+0.44), DLA: 10.45 (-0.10), QQQ: 102.94 (+0.48), AOL: 46.38 (+0.54), BABA: 116.03 (-2.17)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 69.39 (+0.89), COV: 93.80 (+0.92)
Insider Trading Alert - TSLA, COV And AKS Traded By Insiders
at The Street - Tue Nov 11, 9:08AM CST
Stocks with insider trader activity include TSLA, COV and AKS
TSLA: 253.81 (+4.71), COV: 93.80 (+0.92), AKS: 6.37 (+0.13)
Covidien Set to Possibly Pullback After Yesterday's Rally of 1.69%
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 93.80 (+0.92)
Watch for Covidien to Potentially Pullback After Gaining 1.69% Yesterday
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 93.80 (+0.92)
Quarterly Financial Results, Study Results, and Appointments - Research Reports on Covidien, Community Health, Express Scripts, Caterpillar and Boeing
PR Newswire - Fri Nov 07, 7:35AM CST
Today, Analysts Review released its research reports regarding Covidien plc (NYSE: COV), Community Health Systems, Inc. (NYSE: CYH), Express Scripts Holding Company (NASDAQ: ESRX), Caterpillar Inc. (NYSE: CAT) and The Boeing Company (NYSE: BA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7772-100free.
ESRX: 77.67 (-0.17), CYH: 46.37 (-0.48), COV: 93.80 (+0.92), CAT: 101.64 (-1.35), BA: 128.05 (+2.18)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 8.54 (-0.05), MDT: 69.39 (+0.89), UNIS: 3.05 (+0.01), COV: 93.80 (+0.92), SHPG: 202.68 (+2.17), ABBV: 64.05 (+0.29), WAG: 67.09 (-0.35)
Company News for November 06, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:10AM CST
Companies in the News are: ACT,CTSH,COV,TW
ACT: 243.11 (+2.49), COV: 93.80 (+0.92), CTSH: 53.41 (+0.17), TW: 113.43 (-0.62)
SmarTrend Watching for Potential Pullback in Shares of Covidien After 1.36% Gain
Comtex SmarTrend(R) - Wed Nov 05, 4:08PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.69 to a high of $93.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $92.89 on volume of 3.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 93.80 (+0.92)
Covidien Announces Nine-Month Results of DURABILITY Iliac Study, Addition of Iliac Indication for EverFlex(TM) Stent System at VIVA 2014
Business Wire - Wed Nov 05, 3:06PM CST
Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex(TM) stent at the Vascular Interventional Advances (VIVA) 2014 conference. The nine-month results confirm the safety and effectiveness of the EverFlex(TM) and Protege(TM) GPS(TM) self-expanding stent systems* for the treatment of lesions of the common and external iliac arteries.
COV: 93.80 (+0.92)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 69.39 (+0.89), GWPH: 75.60 (+0.28), ABAX: 55.11 (+0.91), COV: 93.80 (+0.92)
Covidien's (COV) CEO José Almeida on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 12:20PM CST
COV: 93.80 (+0.92)
Covidien (COV) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Wed Nov 05, 11:53AM CST
The following Covidien (COV) conference call took place on November 5, 2014, 08:30 AM ET. This is a transcript of that earnings call:
COV: 93.80 (+0.92)
Covidien (COV) Stock Rising on Fourth Quarter Earnings Beat
at The Street - Wed Nov 05, 9:30AM CST
Covidien (COV) shares are climbing after the company beat analysts' fourth quarter earnings and revenue expectations.
COV: 93.80 (+0.92)
Covidien ups earnings 39% in FQ4
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:27AM CST
COV: 93.80 (+0.92)
Covidien (COV) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 7:25AM CST
COV: 93.80 (+0.92)
Recent News posted below.
Covidien Plc. COV other info.
http://investorshangout.com/Covidien-Plc-COV-50596/
COV Covidien Plc. Recent Headline News
Form 8.1 - Covidien
Business Wire - 21 mins ago
Covidien plc:
COV: 93.80 (+0.92)
Insider Trading Alert - CTSH, PSEC And COV Traded By Insiders
at The Street - 1 hr 23 mins ago
Stocks with insider trader activity include CTSH, PSEC and COV
COV: 93.80 (+0.92), CTSH: 53.42 (+0.18), PSEC: 9.74 (+0.05)
Covidien Shares Up 28.9% Since SmarTrend's Buy Recommendation (COV)
Comtex SmarTrend(R) - Wed Nov 12, 9:16AM CST
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 28.91% as of today's recent price of $93.02.
COV: 93.80 (+0.92)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 133.14 (+2.05), MDT: 69.39 (+0.89), C: 53.24 (-0.18), WMT: 82.04 (+2.84), RBS: 11.76 (-0.06), UBS: 17.55 (+0.17), NOK: 8.24 (+0.19), YHOO: 50.17 (-0.43), PBR: 10.44 (-0.12), SPY: 204.32 (+0.36), SAP: 66.44 (-0.01), EBAY: 54.41 (+0.35), JPM: 60.45 (-0.11), BHP: 58.03 (-0.15), AAPL: 113.06 (+1.81), BCS: 14.43 (-0.15), FRM: 6.33 (-0.26), COV: 93.80 (+0.92), HSBC: 50.17 (-0.05), FRGI: 56.07 (-0.60), ZTS: 43.08 (+0.44), DLA: 10.45 (-0.10), QQQ: 102.94 (+0.48), AOL: 46.38 (+0.54), BABA: 116.03 (-2.17)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 69.39 (+0.89), COV: 93.80 (+0.92)
Insider Trading Alert - TSLA, COV And AKS Traded By Insiders
at The Street - Tue Nov 11, 9:08AM CST
Stocks with insider trader activity include TSLA, COV and AKS
TSLA: 253.81 (+4.71), COV: 93.80 (+0.92), AKS: 6.37 (+0.13)
Covidien Set to Possibly Pullback After Yesterday's Rally of 1.69%
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 93.80 (+0.92)
Watch for Covidien to Potentially Pullback After Gaining 1.69% Yesterday
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 93.80 (+0.92)
Quarterly Financial Results, Study Results, and Appointments - Research Reports on Covidien, Community Health, Express Scripts, Caterpillar and Boeing
PR Newswire - Fri Nov 07, 7:35AM CST
Today, Analysts Review released its research reports regarding Covidien plc (NYSE: COV), Community Health Systems, Inc. (NYSE: CYH), Express Scripts Holding Company (NASDAQ: ESRX), Caterpillar Inc. (NYSE: CAT) and The Boeing Company (NYSE: BA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7772-100free.
ESRX: 77.67 (-0.17), CYH: 46.37 (-0.48), COV: 93.80 (+0.92), CAT: 101.64 (-1.35), BA: 128.05 (+2.18)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 8.54 (-0.05), MDT: 69.39 (+0.89), UNIS: 3.05 (+0.01), COV: 93.80 (+0.92), SHPG: 202.68 (+2.17), ABBV: 64.05 (+0.29), WAG: 67.09 (-0.35)
Company News for November 06, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:10AM CST
Companies in the News are: ACT,CTSH,COV,TW
ACT: 243.11 (+2.49), COV: 93.80 (+0.92), CTSH: 53.41 (+0.17), TW: 113.43 (-0.62)
SmarTrend Watching for Potential Pullback in Shares of Covidien After 1.36% Gain
Comtex SmarTrend(R) - Wed Nov 05, 4:08PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.69 to a high of $93.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $92.89 on volume of 3.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 93.80 (+0.92)
Covidien Announces Nine-Month Results of DURABILITY Iliac Study, Addition of Iliac Indication for EverFlex(TM) Stent System at VIVA 2014
Business Wire - Wed Nov 05, 3:06PM CST
Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex(TM) stent at the Vascular Interventional Advances (VIVA) 2014 conference. The nine-month results confirm the safety and effectiveness of the EverFlex(TM) and Protege(TM) GPS(TM) self-expanding stent systems* for the treatment of lesions of the common and external iliac arteries.
COV: 93.80 (+0.92)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 69.39 (+0.89), GWPH: 75.60 (+0.28), ABAX: 55.11 (+0.91), COV: 93.80 (+0.92)
Covidien's (COV) CEO José Almeida on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 12:20PM CST
COV: 93.80 (+0.92)
Covidien (COV) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Wed Nov 05, 11:53AM CST
The following Covidien (COV) conference call took place on November 5, 2014, 08:30 AM ET. This is a transcript of that earnings call:
COV: 93.80 (+0.92)
Covidien (COV) Stock Rising on Fourth Quarter Earnings Beat
at The Street - Wed Nov 05, 9:30AM CST
Covidien (COV) shares are climbing after the company beat analysts' fourth quarter earnings and revenue expectations.
COV: 93.80 (+0.92)
Covidien ups earnings 39% in FQ4
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:27AM CST
COV: 93.80 (+0.92)
Covidien (COV) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 7:25AM CST
COV: 93.80 (+0.92)
